Lymphocytic hypereosinophilic syndrome (Q107461): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Síndrome hipereosinofílica linfocítica é um subtipo da síndrome hipereosinofílica com a presença de uma população de células T monoclonais detectada em conjunto com populações de células T imunofenotipicamente aberrantes. As manifestações são principalmente cutâneas (dermatite eczematosa, nódulos, pápulas, placas, urticária e -ou angioedema com eritrodermia), bem como sintomas gastrointestinais e reumatológicos, tromboembolismo e linfadenopatia. Um subconjunto desenvolve linfoma de células T. | |||
| description / en | description / en | ||
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma. | |||
Revision as of 14:27, 17 August 2026
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_367714724 |
||
| English | Lymphocytic hypereosinophilic syndrome |
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma. |
